Vytronus to demonstrate automated ultrasound technology in clinical development to treat atrial fibrillation
Image: Vytronus is developing the only treatment option for atrial fibrillation that uses low-intensity collimated ultrasound (LICU). Photo: courtesy of PRNewswire / Vytronus, Inc.